323 Preclinical development of AB-1015, an integrated circuit T cell therapy containing an ALPG/MSLN logic gate and FAS/PTPN2 shRNA-miR, for the treatment of ovarian cancer by Irene Scarfò, Stephen Santoro, Aaron Cooper, Jun Feng, Dina Polyak, Michelle Nguyen, James Zhang, Hongruo Yun, Jasper Williams, Jessica Fuhriman, Jennifer McDevitt